<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-31278" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Vulvar Intraepithelial Neoplasia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ayala</surname>
            <given-names>Michael</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Fatehi</surname>
            <given-names>Mary</given-names>
          </name>
          <aff>Nassau University Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Michael Ayala declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mary Fatehi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>18</day>
          <month>10</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-31278.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Vulvar intraepithelial neoplasia (VIN) is a noninvasive squamous lesion and precursor of squamous cell carcinoma of the vulva. This activity reviews the evidence-based approaches&#x000a0;to diagnosing and managing VIN&#x000a0;and&#x000a0;focuses on current advancements in histopathological classification and risk stratification of VIN lesions. The latest updates in topical therapies, laser interventions, and surgical treatments are discussed.&#x000a0;Individualized care plans tailored to patient needs and preferences are emphasized, and&#x000a0;emerging research on HPV vaccination and its potential impact on VIN prevention is explored. This activity highlights the role of the interprofessional team in optimizing patient outcomes through early detection of VIN and effective multidisciplinary interventions.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Apply the 2015 International Society for the Study of Vulvovaginal Disease (ISSVD) classification system to accurately categorize vulvar squamous intraepithelial lesions, distinguishing them from other vulvar conditions.</p></list-item><list-item><p>Identify the risk factors, etiology, and pathophysiology for both subtypes of VIN.</p></list-item><list-item><p>Implement appropriate evidence-based preventive measures, treatment, and surveillance protocols for patients with VIN.</p></list-item><list-item><p>Collaborate with the interprofessional team to provide comprehensive and coordinated care for patients with VIN, optimizing their outcomes and reducing their risk of recurrence.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=31278&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=31278">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-31278.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Vulvar intraepithelial neoplasia (VIN) is a noninvasive squamous lesion and precursor of squamous cell carcinoma (SCC) of the vulva. Because there is no screening test&#x000a0;for VIN, careful examination and biopsy of its various clinical lesions are essential. VIN lesions can be raised, flat, white, gray, or pigmented; diagnosis is made clinically and confirmed with a biopsy.<xref ref-type="bibr" rid="article-31278.r1">[1]</xref></p>
        <p>In 2015, the International Society for the Study of Vulvovaginal Disease (ISSVD) proposed this classification for vulvar squamous intraepithelial lesions (SILs):<xref ref-type="bibr" rid="article-31278.r2">[2]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Low-grade SIL&#x000a0;(LSIL) of the vulva&#x000a0;
<list list-type="bullet"><list-item><p>Vulvar LSIL, flat condyloma, or human papillomavirus (HPV) effect</p></list-item><list-item><p>Previously referred to as VIN 1</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>High-grade SIL&#x000a0;(HSIL) of the vulva
<list list-type="bullet"><list-item><p>Vulvar HSIL, VIN usual type (uVIN)</p></list-item><list-item><p>Previously referred to as VIN 2 and VIN 3</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Differentiated VIN (dVIN)&#x000a0;
<list list-type="bullet"><list-item><p>Previously referred to as VIN simplex type</p></list-item></list>
</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-31278.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>There are&#x000a0;2 different types of VIN: uVIN, which&#x000a0;is associated with HPV, and dVIN, which&#x000a0;is associated with chronic inflammation.&#x000a0;The classification of VIN is based on&#x000a0;histology and does not involve HPV testing.&#x000a0;</p>
        <p>
<bold>dVIN</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Accounts for&#x000a0;only 5% (approximately) of all VIN cases</p>
          </list-item>
          <list-item>
            <p>Correlates with a greater potential for progression to invasive SCC&#x000a0;<bold><xref ref-type="bibr" rid="article-31278.r3">[3]</xref>&#x000a0;</bold></p>
          </list-item>
        </list>
        <p>
<bold>uVIN&#x000a0;</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>An HPV lesion</p>
          </list-item>
          <list-item>
            <p>Increases&#x000a0;the likelihood of other anogenital cancers&#x000a0;<bold><xref ref-type="bibr" rid="article-31278.r3">[3]</xref>&#x000a0;</bold></p>
          </list-item>
        </list>
        <p>Low-grade lesions are not considered premalignant and are treated as condyloma. HPV prevalence in VIN (HSIL) has been reported in 72% to 100% of cases. HPV-16 is the most common HPV type.<xref ref-type="bibr" rid="article-31278.r4">[4]</xref></p>
      </sec>
      <sec id="article-31278.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The incidence of&#x000a0;VIN is higher in White women than non-White women, with the highest reported incidence occurring during the fourth decade of life.<xref ref-type="bibr" rid="article-31278.r3">[3]</xref> uVIN is more common in younger women and can even occur in adolescent girls (average age&#x000a0;at presentation, 40 years), whereas dVIN is more&#x000a0;common in older women (average age&#x000a0;at presentation, 60 years).<xref ref-type="bibr" rid="article-31278.r3">[3]</xref><xref ref-type="bibr" rid="article-31278.r5">[5]</xref><xref ref-type="bibr" rid="article-31278.r6">[6]</xref>&#x000a0;</p>
        <p>HPV DNA is present in most&#x000a0;VIN and SCC; thus, VIN is considered an HPV-associated disease.<xref ref-type="bibr" rid="article-31278.r3">[3]</xref> The&#x000a0;3 most common types of HPV found in&#x000a0;VIN lesions are 16, 18, and 33.<xref ref-type="bibr" rid="article-31278.r3">[3]</xref> Other risk factors for VIN include multiple sexual partners, cigarette smoking, and immunocompromised states such as those found in patients with HIV infection, autoimmune diseases, and organ transplants.<xref ref-type="bibr" rid="article-31278.r5">[5]</xref><xref ref-type="bibr" rid="article-31278.r6">[6]</xref><xref ref-type="bibr" rid="article-31278.r7">[7]</xref>&#x000a0;Risk factors for dVIN include vulvar dermatoses such as lichen sclerosis.&#x000a0;</p>
        <p>A&#x000a0;recent study from the Netherlands of 1100 patients with high-grade VIN showed an increased incidence of both HSIL and dVIN.<xref ref-type="bibr" rid="article-31278.r8">[8]</xref> This change may be due to&#x000a0;greater awareness of VIN, which may have led to increased vulvar biopsies.<xref ref-type="bibr" rid="article-31278.r8">[8]</xref> The study also showed&#x000a0;the 10-year cumulative risk of&#x000a0;vulvar&#x000a0;cancer, which was significantly greater for dVIN than for HSIL.<xref ref-type="bibr" rid="article-31278.r8">[8]</xref>&#x000a0;Another study put the risk of vulvar cancer in dVIN between 33%&#x000a0;and 86%, with time to progression between 9 and 23 months.<xref ref-type="bibr" rid="article-31278.r9">[9]</xref></p>
        <table-wrap id="article-31278.table0" position="float" orientation="portrait">
          <caption>
            <title>Table.&#x000a0;Characteristics of uVIN and dVIN</title>
          </caption>
          <table style="width: 684px; border-color: black;" border="1" cellspacing="1" cellpadding="5">
            <tbody>
              <tr>
                <td style="width: 141.812px;" rowspan="1" colspan="1">
<bold>Characteristics</bold>
</td>
                <td style="width: 170.938px;" rowspan="1" colspan="1">
<bold>uVIN</bold>
</td>
                <td style="width: 239.25px;" rowspan="1" colspan="1">
<bold>dVIN</bold>
</td>
              </tr>
              <tr>
                <td style="width: 141.812px;" rowspan="1" colspan="1">
<bold>Age</bold>
</td>
                <td style="width: 170.938px;" rowspan="1" colspan="1">Younger patients</td>
                <td style="width: 239.25px;" rowspan="1" colspan="1">Older patients</td>
              </tr>
              <tr>
                <td style="width: 141.812px;" rowspan="1" colspan="1">
<bold>Etiology</bold>
</td>
                <td style="width: 170.938px;" rowspan="1" colspan="1">
<p>HPV related</p>
<p>Types 16, 18, 33</p>
</td>
                <td style="width: 239.25px;" rowspan="1" colspan="1">
<p>Vulvar dermatoses related</p>
<p>Lichen sclerosis, Lichen planus</p>
</td>
              </tr>
              <tr>
                <td style="width: 141.812px;" rowspan="1" colspan="1">
<bold>Risk of malignancy</bold>
</td>
                <td style="width: 170.938px;" rowspan="1" colspan="1">Up to 20%</td>
                <td style="width: 239.25px;" rowspan="1" colspan="1">Up to 80%</td>
              </tr>
              <tr>
                <td style="width: 141.812px;" rowspan="1" colspan="1">
<bold>Immunohistochemistry</bold>
</td>
                <td style="width: 170.938px;" rowspan="1" colspan="1">
<p>p53 negative</p>
<p>p16 positive</p>
</td>
                <td style="width: 239.25px;" rowspan="1" colspan="1">
<p>p53&#x000a0;positive</p>
<p>p16&#x000a0;negative</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>Adapted&#x000a0;from&#x000a0;Kavitha A, Deeksha P.<xref ref-type="bibr" rid="article-31278.r10">[10]</xref></p>
      </sec>
      <sec id="article-31278.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>HPV is a single-stranded DNA virus.&#x000a0;When the body fails to produce an effective immune response to high-risk HPV subtypes, uVIN occurs. The viral DNA integrates into host cells, producing oncoproteins E6 and E7, which interfere with normal cellular function.<xref ref-type="bibr" rid="article-31278.r3">[3]</xref>&#x000a0;Mutations&#x000a0;in the tumor suppressor genes <italic toggle="yes">p53</italic> and <italic toggle="yes">PTEN</italic> and microsatellite instability&#x000a0;have also been demonstrated in HPV-independent carcinogenesis.<xref ref-type="bibr" rid="article-31278.r3">[3]</xref><xref ref-type="bibr" rid="article-31278.r5">[5]</xref><xref ref-type="bibr" rid="article-31278.r6">[6]</xref>&#x000a0;In contrast, dVIN appears to be related to chronic oxidative genetic damage that promotes similarly aberrant cellular function. Lichen sclerosis and lichen planus are examples of chronic, inflammatory changes&#x000a0;in the normal epithelium&#x000a0;that are associated with&#x000a0;SCC of the vulva.<xref ref-type="bibr" rid="article-31278.r3">[3]</xref><xref ref-type="bibr" rid="article-31278.r5">[5]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-31278.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>The histological feature necessary for diagnosing VIN is the proliferation of atypical basal cells. The&#x000a0;5 criteria for atypia are basal layer involvement, enlarged nuclei, hyperchromasia, pleomorphic cells, and increased numbers of mitotic figures.<xref ref-type="bibr" rid="article-31278.r3">[3]</xref>&#x000a0;Aside from atypia, both uVIN and dVIN have distinctive features.</p>
        <p>In uVIN, proliferation begins at the basal layer and involves partial to full thickness of the squamous epithelium.<xref ref-type="bibr" rid="article-31278.r5">[5]</xref>&#x000a0;The uVIN lesions exhibit basal cells with large, dark nuclei and small amounts of basophilic cytoplasm.<xref ref-type="bibr" rid="article-31278.r3">[3]</xref> However, approaching the surface epithelium, atypical basaloid cells may mature to develop an abundant eosinophilic cytoplasm.<xref ref-type="bibr" rid="article-31278.r3">[3]</xref> The more mature squamous cells often display a cytopathic change termed koilocytosis.<xref ref-type="bibr" rid="article-31278.r3">[3]</xref> Warty&#x000a0;and basaloid subtypes of uVIN are described; both forms are premalignant and treated identically.<xref ref-type="bibr" rid="article-31278.r3">[3]</xref></p>
        <p>A&#x000a0;high oncogenic potential exists with dVIN, and&#x000a0;dVIN characteristics are more subtle.<xref ref-type="bibr" rid="article-31278.r5">[5]</xref> Key features of dVIN are a thickened epidermis, parakeratosis, basal nuclear atypia, and premature maturation above the basal layer. These premature cells possess eosinophilic cytoplasm, intracellular prickles, large nuclei, and prominent nucleoli.<xref ref-type="bibr" rid="article-31278.r3">[3]</xref> The relatively high degree of differentiation often present in dVIN lesions&#x000a0;can be&#x000a0;mistakenly diagnosed as benign.<xref ref-type="bibr" rid="article-31278.r5">[5]</xref></p>
        <p>Immunohistochemistry markers can be used to differentiate between uVIN and dVIN. P53 positivity and p16 negativity support a dVIN diagnosis,&#x000a0;whereas the converse supports a uVIN diagnosis.<xref ref-type="bibr" rid="article-31278.r3">[3]</xref><xref ref-type="bibr" rid="article-31278.r5">[5]</xref><xref ref-type="bibr" rid="article-31278.r6">[6]</xref>&#x000a0;VIN&#x000a0;with a TP53 mutation&#x000a0;may be a significant risk factor for both VIN recurrence and the development of invasive disease.<xref ref-type="bibr" rid="article-31278.r10">[10]</xref></p>
      </sec>
      <sec id="article-31278.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>VIN is a clinical diagnosis.<xref ref-type="bibr" rid="article-31278.r3">[3]</xref> There is no routine screening test for VIN; however, abnormal cytology or a positive high-risk HPV test used in cervical cancer screening warrants an independent visual assessment of the vulva.<xref ref-type="bibr" rid="article-31278.r3">[3]</xref> Acetic acid alone is not recommended for diagnosis&#x000a0;because&#x000a0;the whitened color of observed lesions is not specific to vulvar intraepithelial neoplasia.<xref ref-type="bibr" rid="article-31278.r3">[3]</xref> One should note the following on examination of the vulva for lesions seen: location, number, size, shape, color, and thickness.</p>
        <p>VIN is generally multifocal. Lesions&#x000a0;may be raised, verrucous, and white; however, they may also be red, gray, or pigmented. There is no pathognomic appearance, hence the need for a biopsy of any abnormal vulvar lesion. Different patterns may be present in the same patient.<xref ref-type="bibr" rid="article-31278.r11">[11]</xref></p>
      </sec>
      <sec id="article-31278.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>uVIN and dVIN are clinically dissimilar: uVIN is commonly multifocal and elevated, found&#x000a0;around the introitus and labia majora;<xref ref-type="bibr" rid="article-31278.r3">[3]</xref>&#x000a0;dVIN lesions demonstrate poorly demarcated pink or white plaques (often associated with lichen sclerosis or lichen planus) and are refractory to medical therapy.<xref ref-type="bibr" rid="article-31278.r3">[3]</xref><xref ref-type="bibr" rid="article-31278.r6">[6]</xref>&#x000a0;</p>
        <p>A colposcopic examination of the vulva can be&#x000a0;performed to&#x000a0;complement a visual exam; a&#x000a0;hand lens with magnification can also be used. Toluidine solution to identify VIN&#x000a0;(Collins test) has low specificity and is not recommended.<xref ref-type="bibr" rid="article-31278.r12">[12]</xref>&#x000a0;</p>
        <p>All portions of the vulva, including the labia majora and minora, vestibule, clitoris, terminal urethra, perineum, and perianal area, should be examined. If high-grade lesions are discovered, an examination and cytology of the anal canal may be necessary. Up to 18% of&#x000a0;patients with vulvar HSIL&#x000a0;may have anal lesions.<xref ref-type="bibr" rid="article-31278.r11">[11]</xref>&#x000a0;Any observed vulvar lesions require a biopsy to determine appropriate treatment.<xref ref-type="bibr" rid="article-31278.r3">[3]</xref></p>
      </sec>
      <sec id="article-31278.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The ideal treatment of&#x000a0;VIN involves the complete destruction of the lesion, symptom improvement, and preservation of vulvar function.<xref ref-type="bibr" rid="article-31278.r3">[3]</xref>&#x000a0;Treatment options include surgical, medical, or expectant management. Prevention has, and will ultimately continue to, decrease the disease burden.</p>
        <p>
<bold>uVIN</bold>
</p>
        <p>
<bold>Excisional Treatment</bold>
</p>
        <p>Cold knife surgery and loop electrosurgical excision procedure (LEEP) are the preferred treatments for uVIN. The recommendations for negative surgical margins are a 5-mm peripheral margin and a 4-mm deep margin.&#x000a0;However, margin status does not predict the risk of invasive or recurrent disease.<xref ref-type="bibr" rid="article-31278.r3">[3]</xref></p>
        <p>An alternative treatment is CO<sub>2</sub> laser ablation, but vaporization of the diseased tissue precludes a pathologic specimen.<xref ref-type="bibr" rid="article-31278.r3">[3]</xref>&#x000a0;Although the advantage of laser ablation is the preservation of normal anatomy with less scarring, the cost&#x000a0;is an increased risk of recurrence.<xref ref-type="bibr" rid="article-31278.r7">[7]</xref></p>
        <p>
<bold>Medical Treatment</bold>
</p>
        <p>Imiquimod is an immune-modifying drug that induces proinflammatory cytokines with&#x000a0;antiviral and antitumor properties and enhances innate and cell-mediated immunity against HPV.<xref ref-type="bibr" rid="article-31278.r3">[3]</xref> Trials using Imiquimod have demonstrated efficacy&#x000a0;comparable to surgical results, and it can be an adjunct to excision with positive margins or recurrent cases.<xref ref-type="bibr" rid="article-31278.r13">[13]</xref> Local irritation, erythema, and erosions may occur. Complete response rates in&#x000a0;database reviews were 51%, and partial response rates were 25%.<xref ref-type="bibr" rid="article-31278.r14">[14]</xref></p>
        <p>Other medical options for treatment are utilized less often. Cidofovir is an acyclic nucleoside analog with antiviral properties that promotes apoptosis of HPV-infected cells.<xref ref-type="bibr" rid="article-31278.r3">[3]</xref>&#x000a0;Photodynamic therapy is an option in conjunction with nonthermal light to generate oxygen-induced cellular death.<xref ref-type="bibr" rid="article-31278.r3">[3]</xref>&#x000a0;</p>
        <p>
<bold>dVIN</bold>
</p>
        <p>
<bold>Excisional Treatment</bold>
</p>
        <p>dVIN is associated with lichen sclerosis and invasive disease&#x000a0;(specifically, SCC of the vulva).<xref ref-type="bibr" rid="article-31278.r15">[15]</xref>&#x000a0;Recurrence rates for dVIN are much higher than those for uVIN.<xref ref-type="bibr" rid="article-31278.r16">[16]</xref> Treatment of these lesions should include surgical excision with a scalpel, LEEP, or laser. Wide local excision is preferable as the initial treatment.<xref ref-type="bibr" rid="article-31278.r17">[17]</xref><xref ref-type="bibr" rid="article-31278.r18">[18]</xref><xref ref-type="bibr" rid="article-31278.r19">[19]</xref></p>
        <p>
<bold>Expectant Management</bold>
</p>
        <p>Spontaneous regression is reported in uVIN but is adversely influenced by the increasing age of the patient, clinical presentation with chronic immunosuppression and multifocal disease, and the longer duration of the lesion.<xref ref-type="bibr" rid="article-31278.r3">[3]</xref>&#x000a0;Close surveillance of these patients is required even after spontaneous regression occurs. Women younger than 35 years have a higher rate of regression. Pregnancy has been reported to increase both spontaneous regressions and the progression of premalignant vulvar lesions.<xref ref-type="bibr" rid="article-31278.r5">[5]</xref></p>
        <p>
<bold>Preventative Management</bold>
</p>
        <p>HPV vaccination has reduced the incidence of&#x000a0;VIN in young women.<xref ref-type="bibr" rid="article-31278.r5">[5]</xref> However, HPV vaccination is designed as a prophylactic measure, not a treatment for confirmed lesions.<xref ref-type="bibr" rid="article-31278.r6">[6]</xref></p>
      </sec>
      <sec id="article-31278.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Any observed lesion of the vulva requires a biopsy for diagnosis. Benign lesions include common dermatopathology such as lichen simplex, lichen sclerosis, or lichen planus. Vulvar lesions may also result from infections such as vestibulitis, candidiasis, or herpes. Genital warts, psoriasis, condyloma acuminata, and seborrheic keratosis are also included&#x000a0;in the differential diagnosis.&#x000a0;VIN is a preinvasive lesion that may appear similar to these more common skin changes or common&#x000a0;malignancies such as basal cell carcinoma, SCC, Paget disease, or melanoma. Treatment without biopsy confirmation risks progression and delays the diagnosis of potential malignancy.<xref ref-type="bibr" rid="article-31278.r20">[20]</xref></p>
      </sec>
      <sec id="article-31278.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of biopsy-confirmed&#x000a0;VIN that receives prompt treatment is uniformly good; there is rarely progression to invasive cancer unless treatment is declined or markedly delayed. Without treatment, uVIN can progress to invasive cancer in 6 to 7 years,&#x000a0;whereas in untreated dVIN, vulvar cancer can result in 2 to 4 years.</p>
        <p>Long-term surveillance is necessary, given the high recurrence rate after any treatment and the possibility of long-term recurrences. Follow-up is recommended every 6 to 12 months (for at least 5 years for uVIN, indefinitely for dVIN).</p>
        <p>A third to one-half&#x000a0;of patients may have a recurrence of their disease, and 25% of patients can experience late recurrences. Risk factors for recurrence include large lesion size, age (50 years&#x000a0;and older), positive excision margins, multifocal disease, immunosuppression, and tobacco use.<xref ref-type="bibr" rid="article-31278.r21">[21]</xref><xref ref-type="bibr" rid="article-31278.r10">[10]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-31278.s12" sec-type="Complications">
        <title>Complications</title>
        <p>The most severe complication of untreated&#x000a0;VIN is progression to invasive carcinoma. Malignant disease of the vulva necessitates more involved radical resection, commonly associated with perioperative morbidities such as pain, infection, wound dehiscence, and altered vulvar appearance. Surgical resection complications depend on the treated lesions' location, distribution, and size. Topical therapies may result in irritation, burning, or ulceration.</p>
      </sec>
      <sec id="article-31278.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>In age-appropriate patients, the use of the HPV vaccine should be discussed to prevent lower genital tract disease, including condyloma and uVIN.<xref ref-type="bibr" rid="article-31278.r22">[22]</xref>&#x000a0;Theoretically, the 9-valent HPV vaccination can reduce uVIN risk by 80% to 90%.&#x000a0;Immunization does not decrease the risk of dVIN.</p>
        <p>Patients with a history of&#x000a0;genital warts or previous uVIN should be encouraged to stop smoking. The need for continued life-long observation is also an essential part of patient education.</p>
        <p>Effective and timely treatment of vulval skin disorders such as lichen sclerosis and lichen planus may reduce the risk of dVIN and vulvar cancer.&#x000a0;</p>
      </sec>
      <sec id="article-31278.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>There are&#x000a0;2 types of VIN: uVIN&#x000a0;related to HPV infection and&#x000a0;dVIN&#x000a0;related to chronic oxidative damage. uVIN is multifocal and multicentric,&#x000a0;whereas dVIN is unifocal and difficult to distinguish from benign lesions.<xref ref-type="bibr" rid="article-31278.r3">[3]</xref>&#x000a0;dVIN only accounts for a small percentage of all VIN lesions and has a higher association with invasive cancer than uVIN. Most uVIN is related to HPV-16; however, there are reports of other high-risk HPV subtypes in histologically confirmed uVIN.<xref ref-type="bibr" rid="article-31278.r3">[3]</xref><xref ref-type="bibr" rid="article-31278.r5">[5]</xref><xref ref-type="bibr" rid="article-31278.r6">[6]</xref>&#x000a0;Failure of the immune system to produce an immune response against HPV allows viral DNA to become integrated into the host DNA, which can promote disruption of cellular function and transformation, causing VIN.</p>
      </sec>
      <sec id="article-31278.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>When the primary care clinician, internist, or nurse practitioner suspects a patient may have VIN, referral to a gynecologist is recommended.&#x000a0;The diagnosis is made clinically with inspection and biopsy, often utilizing immunohistochemistry. Treatment depends on lesion type, location, size, and extent of disease. Lifelong surveillance is essential since resection of individual lesions does not guarantee the prevention of invasive cancer.<xref ref-type="bibr" rid="article-31278.r3">[3]</xref>&#x000a0;</p>
        <p>Healthcare professionals should strongly encourage HPV vaccination to reduce the incidence of VIN and invasive vulvar cancer.<xref ref-type="bibr" rid="article-31278.r3">[3]</xref>&#x000a0;VIN prevention and management,&#x000a0;including&#x000a0;long-term follow-up care, is best accomplished&#x000a0;by an interprofessional team that includes physicians, advanced care practitioners, and nurses to achieve the best possible patient outcomes.&#x000a0;</p>
      </sec>
      <sec id="article-31278.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=31278&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=31278">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/womens-health/vulvar-intraepithelial-neoplasia/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=31278">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/31278/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=31278">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-31278.s17">
        <title>References</title>
        <ref id="article-31278.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <article-title>Committee Opinion No. 675: Management of Vulvar Intraepithelial Neoplasia: Correction.</article-title>
            <source>Obstet Gynecol</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>129</volume>
            <issue>1</issue>
            <fpage>209</fpage>
            <pub-id pub-id-type="pmid">28092302</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31278.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bornstein</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bogliatto</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Haefner</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Stockdale</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Preti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bohl</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Reutter</surname>
                <given-names>J</given-names>
              </name>
              <collab>ISSVD Terminology Committee</collab>
            </person-group>
            <article-title>The 2015 International Society for the Study of Vulvovaginal Disease (ISSVD) Terminology of Vulvar Squamous Intraepithelial Lesions.</article-title>
            <source>Obstet Gynecol</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>127</volume>
            <issue>2</issue>
            <fpage>264</fpage>
            <page-range>264-8</page-range>
            <pub-id pub-id-type="pmid">26942352</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31278.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Preti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Scurry</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Marchitelli</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Micheletti</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Vulvar intraepithelial neoplasia.</article-title>
            <source>Best Pract Res Clin Obstet Gynaecol</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>28</volume>
            <issue>7</issue>
            <fpage>1051</fpage>
            <page-range>1051-62</page-range>
            <pub-id pub-id-type="pmid">25106700</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31278.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lebreton</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Carton</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Brousse</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lavou&#x000e9;</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Body</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lev&#x000ea;que</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nyangoh-Timoh</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Vulvar intraepithelial neoplasia: Classification, epidemiology, diagnosis, and management.</article-title>
            <source>J Gynecol Obstet Hum Reprod</source>
            <year>2020</year>
            <month>Nov</month>
            <volume>49</volume>
            <issue>9</issue>
            <fpage>101801</fpage>
            <pub-id pub-id-type="pmid">32417455</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31278.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Del Pino</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rodriguez-Carunchio</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ordi</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Pathways of vulvar intraepithelial neoplasia and squamous cell carcinoma.</article-title>
            <source>Histopathology</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>62</volume>
            <issue>1</issue>
            <fpage>161</fpage>
            <page-range>161-75</page-range>
            <pub-id pub-id-type="pmid">23190170</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31278.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>L&#x000e9;onard</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kridelka</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Delbecque</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Goffin</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Demoulin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Doyen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Delvenne</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>A clinical and pathological overview of vulvar condyloma acuminatum, intraepithelial neoplasia, and squamous cell carcinoma.</article-title>
            <source>Biomed Res Int</source>
            <year>2014</year>
            <volume>2014</volume>
            <fpage>480573</fpage>
            <pub-id pub-id-type="pmid">24719870</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31278.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wallbillich</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Rhodes</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Milbourne</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Munsell</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Frumovitz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Trimble</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Schmeler</surname>
                <given-names>KM</given-names>
              </name>
            </person-group>
            <article-title>Vulvar intraepithelial neoplasia (VIN 2/3): comparing clinical outcomes and evaluating risk factors for recurrence.</article-title>
            <source>Gynecol Oncol</source>
            <year>2012</year>
            <month>Nov</month>
            <volume>127</volume>
            <issue>2</issue>
            <fpage>312</fpage>
            <page-range>312-5</page-range>
            <pub-id pub-id-type="pmid">22867736</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31278.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thuijs</surname>
                <given-names>NB</given-names>
              </name>
              <name>
                <surname>van Beurden</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bruggink</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Steenbergen</surname>
                <given-names>RDM</given-names>
              </name>
              <name>
                <surname>Berkhof</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bleeker</surname>
                <given-names>MCG</given-names>
              </name>
            </person-group>
            <article-title>Vulvar intraepithelial neoplasia: Incidence and long-term risk of vulvar squamous cell carcinoma.</article-title>
            <source>Int J Cancer</source>
            <year>2021</year>
            <month>Jan</month>
            <day>01</day>
            <volume>148</volume>
            <issue>1</issue>
            <fpage>90</fpage>
            <page-range>90-98</page-range>
            <pub-id pub-id-type="pmid">32638382</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31278.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vieira-Baptista</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>P&#x000e9;rez-L&#x000f3;pez</surname>
                <given-names>FR</given-names>
              </name>
              <name>
                <surname>L&#x000f3;pez-Baena</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Stockdale</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Preti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bornstein</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Risk of Development of Vulvar Cancer in Women With Lichen Sclerosus or Lichen Planus: A Systematic Review.</article-title>
            <source>J Low Genit Tract Dis</source>
            <year>2022</year>
            <month>Jul</month>
            <day>01</day>
            <volume>26</volume>
            <issue>3</issue>
            <fpage>250</fpage>
            <page-range>250-257</page-range>
            <pub-id pub-id-type="pmid">35285455</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31278.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jamieson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tse</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Brar</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sadownik</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Proctor</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>A Systematic Review of Risk Factors for Development, Recurrence, and Progression of Vulvar Intraepithelial Neoplasia.</article-title>
            <source>J Low Genit Tract Dis</source>
            <year>2022</year>
            <month>Apr</month>
            <day>01</day>
            <volume>26</volume>
            <issue>2</issue>
            <fpage>140</fpage>
            <page-range>140-146</page-range>
            <pub-id pub-id-type="pmid">35249976</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31278.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kesi&#x00107;</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Vieira-Baptista</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Stockdale</surname>
                <given-names>CK</given-names>
              </name>
            </person-group>
            <article-title>Early Diagnostics of Vulvar Intraepithelial Neoplasia.</article-title>
            <source>Cancers (Basel)</source>
            <year>2022</year>
            <month>Apr</month>
            <day>04</day>
            <volume>14</volume>
            <issue>7</issue>
            <pub-id pub-id-type="pmid">35406594</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31278.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <article-title>Diagnosis and Management of Vulvar Skin Disorders: ACOG Practice Bulletin Summary, Number 224.</article-title>
            <source>Obstet Gynecol</source>
            <year>2020</year>
            <month>Jul</month>
            <volume>136</volume>
            <issue>1</issue>
            <fpage>222</fpage>
            <page-range>222-225</page-range>
            <pub-id pub-id-type="pmid">32590722</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31278.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Trutnovsky</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Reich</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Joura</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Holter</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ciresa-K&#x000f6;nig</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Widschwendter</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schauer</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bogner</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Jan</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Boandl</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kalteis</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Regauer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tamussino</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Topical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial.</article-title>
            <source>Lancet</source>
            <year>2022</year>
            <month>May</month>
            <day>07</day>
            <volume>399</volume>
            <issue>10337</issue>
            <fpage>1790</fpage>
            <page-range>1790-1798</page-range>
            <pub-id pub-id-type="pmid">35483400</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31278.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mahto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nathan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>O'Mahony</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>More than a decade on: review of the use of imiquimod in lower anogenital intraepithelial neoplasia.</article-title>
            <source>Int J STD AIDS</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>21</volume>
            <issue>1</issue>
            <fpage>8</fpage>
            <page-range>8-16</page-range>
            <pub-id pub-id-type="pmid">20029061</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31278.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van de Nieuwenhof</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>van Kempen</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>de Hullu</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Bekkers</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Bulten</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Melchers</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Massuger</surname>
                <given-names>LF</given-names>
              </name>
            </person-group>
            <article-title>The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned.</article-title>
            <source>Cancer Epidemiol Biomarkers Prev</source>
            <year>2009</year>
            <month>Jul</month>
            <volume>18</volume>
            <issue>7</issue>
            <fpage>2061</fpage>
            <page-range>2061-7</page-range>
            <pub-id pub-id-type="pmid">19567503</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31278.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eva</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Ganesan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Honest</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Malik</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Luesley</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Vulval squamous cell carcinoma occurring on a background of differentiated vulval intraepithelial neoplasia is more likely to recur: a review of 154 cases.</article-title>
            <source>J Reprod Med</source>
            <year>2008</year>
            <month>Jun</month>
            <volume>53</volume>
            <issue>6</issue>
            <fpage>397</fpage>
            <page-range>397-401</page-range>
            <pub-id pub-id-type="pmid">18664055</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31278.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Liang</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Differentiated Vulvar Intraepithelial Neoplasia: A Brief Review of Clinicopathologic Features.</article-title>
            <source>Arch Pathol Lab Med</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>143</volume>
            <issue>6</issue>
            <fpage>768</fpage>
            <page-range>768-771</page-range>
            <pub-id pub-id-type="pmid">30640512</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31278.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grimm</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Prieske</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mathey</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kuerti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Burandt</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Schmalfeldt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Woelber</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Superficially invasive stage IA vulvar squamous cell carcinoma-therapy and prognosis.</article-title>
            <source>Int J Gynecol Cancer</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>466</fpage>
            <page-range>466-473</page-range>
            <pub-id pub-id-type="pmid">30622111</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31278.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bryan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Barbara</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Olaitan</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>HPV vaccine in the treatment of usual type vulval and vaginal intraepithelial neoplasia: a systematic review.</article-title>
            <source>BMC Womens Health</source>
            <year>2019</year>
            <month>Jan</month>
            <day>07</day>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <pub-id pub-id-type="pmid">30616555</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31278.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dockery</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Soper</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>Vulvar Intraepithelial Neoplasia: A Review of the Disease and Current Management.</article-title>
            <source>Obstet Gynecol Surv</source>
            <year>2021</year>
            <month>Jan</month>
            <volume>76</volume>
            <issue>1</issue>
            <fpage>55</fpage>
            <page-range>55-62</page-range>
            <pub-id pub-id-type="pmid">33506879</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31278.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Satmary</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Holschneider</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Brunette</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Natarajan</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Vulvar intraepithelial neoplasia: Risk factors for recurrence.</article-title>
            <source>Gynecol Oncol</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>148</volume>
            <issue>1</issue>
            <fpage>126</fpage>
            <page-range>126-131</page-range>
            <pub-id pub-id-type="pmid">29126556</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31278.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Issanov</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Karim</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Aimagambetova</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Dummer</surname>
                <given-names>TJB</given-names>
              </name>
            </person-group>
            <article-title>Does Vaccination Protect against Human Papillomavirus-Related Cancers? Preliminary Findings from the United States National Health and Nutrition Examination Survey (2011-2018).</article-title>
            <source>Vaccines (Basel)</source>
            <year>2022</year>
            <month>Dec</month>
            <day>10</day>
            <volume>10</volume>
            <issue>12</issue>
            <pub-id pub-id-type="pmid">36560523</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
